Body composition in patients with radioactive iodine-refractory, advanced differentiated thyroid cancer treated with sorafenib or placebo: A retrospective analysis of the Phase III DECISION Trial - Huillard, O; Jouinot, A; Tlemsani, C (Thyroid, 2019)
et al.